Please try another search
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products in the province of British Columbia, Canada, and the state of Utah. It develops barium, iodine-based APIs, and imaging contrast agents for medical radiology. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada.
Name | Age | Since | Title |
---|---|---|---|
Brent Willis | 52 | 2015 | President, CEO & Director |
Deborah A. Baumgarten | - | - | Member of Scientific Advisory Board |
Bradley Craig Willis | 52 | 2014 | Founder, COO & Director |
Thomas Lauenstein | - | - | Member of Scientific Advisory Board |
Alec J. Megibow | - | - | Member of Scientific Advisory Board |
Ralph C. Hesje | - | 2021 | Independent Director |
Sat Somers | - | - | Member of Scientific Advisory Board |
C. Dan Johnson | - | - | Member of Scientific Advisory Board |
Kevin Richard McBeth | - | 2023 | Director |
Agustin V. Gago | 64 | 2024 | Director |
Eric S. Pommer | 73 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review